Liu Y, Liu Y, Wang Q, Song Y, Chen S, Cheng B, Zhang Y, Cui Z, Wu Z, Zhu C
AOD9604 is a modified fragment of human growth hormone, primarily researched for its lipolytic (fat-reducing) properties without promoting cell proliferation or insulin resistance
This specific sequence was identified through systematic research aimed at isolating the lipolytic (fat-breaking) properties of growth hormone while eliminating the growth-promoting, diabetogenic, and other potentially problematic effects associated with full-length hGH therapy
It also promotes the formation of new blood vessels, a process called angiogenesis, which improves the delivery of oxygen and nutrients to damaged tissues, further speeding up recovery